Their results indicated that inhibition of LYN by Dasatinib reduces the population of MDSCs and that LYN overexpression correlated with stromal MDSCs and TAMs, resulting consequently with a poor prognosis of HNSCC patients [107]. Here, LYN is linked to head and neck squamous cell carcinoma.